The results of an in vivo experiment conducted by Yue et al. demonstrated that different doses of atorvastatin could alleviate kidney injury as well as reduce apoptosis and inflammatory factor levels (IL-1β, IL-6 and MCP-1) in the kidneys of CI-AKI rats [8]. This evidence concerns the gene CCL2 and acute kidney injury.